237 related articles for article (PubMed ID: 31103551)
1. Poor Utilization of Nimodipine in Aneurysmal Subarachnoid Hemorrhage.
Hajizadeh Barfejani A; Rabinstein AA; Wijdicks EFM; Clark SL
J Stroke Cerebrovasc Dis; 2019 Aug; 28(8):2155-2158. PubMed ID: 31103551
[TBL] [Abstract][Full Text] [Related]
2. Nimodipine Dose Reductions in the Treatment of Patients with Aneurysmal Subarachnoid Hemorrhage.
Sandow N; Diesing D; Sarrafzadeh A; Vajkoczy P; Wolf S
Neurocrit Care; 2016 Aug; 25(1):29-39. PubMed ID: 26690937
[TBL] [Abstract][Full Text] [Related]
3. Dangers of outpatient nimodipine use after spontaneous subarachnoid hemorrhage in accordance with the Comprehensive Stroke Center guidelines.
Chen CJ; Turnage C; Sokolowski JD; Kumar JS; Kalani MY; Park MS
J Clin Neurosci; 2018 Jun; 52():151-152. PubMed ID: 29656002
[TBL] [Abstract][Full Text] [Related]
4. Clinical Trial Protocol: Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy, and Safety Study Comparing EG-1962 to Standard of Care Oral Nimodipine in Adults with Aneurysmal Subarachnoid Hemorrhage [NEWTON-2 (Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After SubarachNoid Hemorrhage)].
Hänggi D; Etminan N; Mayer SA; Aldrich EF; Diringer MN; Schmutzhard E; Faleck HJ; Ng D; Saville BR; Macdonald RL;
Neurocrit Care; 2019 Feb; 30(1):88-97. PubMed ID: 30014184
[TBL] [Abstract][Full Text] [Related]
5. Hypotensive effect of nimodipine during treatment for aneurysmal subarachnoid haemorrhage.
Porchet F; Chioléro R; de Tribolet N
Acta Neurochir (Wien); 1995; 137(1-2):62-9. PubMed ID: 8748871
[TBL] [Abstract][Full Text] [Related]
6. Effects of 14 Versus 21 Days of Nimodipine Therapy on Neurological Outcomes in Aneurysmal Subarachnoid Hemorrhage Patients.
Cho S; Bales J; Tran TK; Korab G; Khandelwal N; Joffe AM
Ann Pharmacother; 2016 Sep; 50(9):718-24. PubMed ID: 27273676
[TBL] [Abstract][Full Text] [Related]
7. Incidence of Arterial Hypotension in Patients Receiving Peroral or Continuous Intra-arterial Nimodipine After Aneurysmal or Perimesencephalic Subarachnoid Hemorrhage.
Kieninger M; Gruber M; Knott I; Dettmer K; Oefner PJ; Bele S; Wendl C; Tuemmler S; Graf B; Eissnert C
Neurocrit Care; 2019 Aug; 31(1):32-39. PubMed ID: 30725331
[TBL] [Abstract][Full Text] [Related]
8. Intra-arterial nimodipine infusion for cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage.
Cho WS; Kang HS; Kim JE; Kwon OK; Oh CW; Son YJ; Know BJ; Jung C; Hang MH
Interv Neuroradiol; 2011 Jun; 17(2):169-78. PubMed ID: 21696654
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenomics of Cytochrome P450 of Nimodipine Metabolism After Aneurysmal Subarachnoid Hemorrhage.
Peacock SH; James C; Turnbull MT; Cowart JB; Reid JM; Freeman WD
J Neurosci Nurs; 2019 Oct; 51(5):238-242. PubMed ID: 31469704
[TBL] [Abstract][Full Text] [Related]
10. Comparison of nimodipine formulations and administration techniques via enteral feeding tubes in patients with aneurysmal subarachnoid hemorrhage: A multicenter retrospective cohort study.
Mahmoud SH; Hefny FR; Panos NG; Delucilla L; Ngan Z; Perreault MM; Hamilton LA; Rowe AS; Buschur PL; Owusu-Guha J; Almohaish S; Sandler M; Armahizer MJ; Barra ME; Cook AM; Barthol CA; Hintze TD; Cantin A; Traeger J; Blunck JR; Shewmaker J; Burgess SV; Kaupp K; Brown CS; Clark SL; Wieruszewski ED; Tesoro EP; Ammar AA; Ammar MA; Binning MJ; Naydin S; Fox N; Peters DM; Mahmoud LN; Keegan SP; Brophy GM
Pharmacotherapy; 2023 Apr; 43(4):279-290. PubMed ID: 36880540
[TBL] [Abstract][Full Text] [Related]
11. Nimodipine-associated standard dose reductions and neurologic outcomes after aneurysmal subarachnoid hemorrhage: the era of pharmacogenomics.
Vázquez-Medina A; Turnbull MT; James CL; Cowart JB; Lesser E; Carter RE; Ross OA; Miller DA; Meschia JF; De Jesús Espinosa A; Weinshilboum R; Freeman WD
Pharmacogenomics J; 2024 Jun; 24(4):19. PubMed ID: 38890281
[TBL] [Abstract][Full Text] [Related]
12. NEWTON: Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage.
Hänggi D; Etminan N; Macdonald RL; Steiger HJ; Mayer SA; Aldrich F; Diringer MN; Hoh BL; Mocco J; Strange P; Faleck HJ; Miller M
Neurocrit Care; 2015 Oct; 23(2):274-84. PubMed ID: 25678453
[TBL] [Abstract][Full Text] [Related]
13. Impact of Early Versus Late Intravenous Followed by Oral Nimodipine Treatment on the Occurrence of Delayed Cerebral Ischemia Among Patients With Aneurysm Subarachnoid Hemorrhage.
Samseethong T; Suansanae T; Veerasarn K; Liengudom A; Suthisisang C
Ann Pharmacother; 2018 Nov; 52(11):1061-1069. PubMed ID: 29783859
[TBL] [Abstract][Full Text] [Related]
14. Continuous selective intraarterial infusion of nimodipine for therapy of refractory cerebral vasospasm.
Wolf S; Martin H; Landscheidt JF; Rodiek SO; Schürer L; Lumenta CB
Neurocrit Care; 2010 Jun; 12(3):346-51. PubMed ID: 20033353
[TBL] [Abstract][Full Text] [Related]
15. Nimodipine after aneurysmal subarachnoid hemorrhage: Fourteen-day course for patients that meet criteria for early hospital discharge.
Sokolowski JD; Chen CJ; Soldozy S; Mastorakos P; Burke RM; Nguyen JM; Myers KM; Kalani MYS; Park MS
Clin Neurol Neurosurg; 2021 Jan; 200():106299. PubMed ID: 33092929
[TBL] [Abstract][Full Text] [Related]
16. Outcome of Oral and Intra-arterial Nimodipine Administration After Aneurysmal Subarachnoid Haemorrhage - A Single-centre Study.
Ehrlich G; Kirschning T; Wenz H; Hegewald AA; Neumaier-Probst E; Seiz-Rosenhagen M
In Vivo; 2019; 33(6):1967-1975. PubMed ID: 31662526
[TBL] [Abstract][Full Text] [Related]
17. Mass spectrometry-based method for quantification of nimodipine and glutamate in cerebrospinal fluid. Pilot study with patients after aneurysmal subarachnoid haemorrhage.
Mindt S; Tokhi U; Hedtke M; Groß HJ; Hänggi D
J Clin Pharm Ther; 2020 Feb; 45(1):81-87. PubMed ID: 31421063
[TBL] [Abstract][Full Text] [Related]
18. Single-Dose Intraventricular Nimodipine Microparticles Versus Oral Nimodipine for Aneurysmal Subarachnoid Hemorrhage.
Carlson AP; Hänggi D; Wong GK; Etminan N; Mayer SA; Aldrich F; Diringer MN; Schmutzhard E; Faleck HJ; Ng D; Saville BR; Bleck T; Grubb R; Miller M; Suarez JI; Proskin HM; Macdonald RL;
Stroke; 2020 Apr; 51(4):1142-1149. PubMed ID: 32138631
[TBL] [Abstract][Full Text] [Related]
19. A randomized outcome study of enteral versus intravenous nimodipine in 171 patients after acute aneurysmal subarachnoid hemorrhage.
Soppi V; Karamanakos PN; Koivisto T; Kurki MI; Vanninen R; Jaaskelainen JE; Rinne J
World Neurosurg; 2012 Jul; 78(1-2):101-9. PubMed ID: 22120252
[TBL] [Abstract][Full Text] [Related]
20. Randomized, Open-Label, Phase 1/2a Study to Determine the Maximum Tolerated Dose of Intraventricular Sustained Release Nimodipine for Subarachnoid Hemorrhage (NEWTON [Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage]).
Hänggi D; Etminan N; Aldrich F; Steiger HJ; Mayer SA; Diringer MN; Hoh BL; Mocco J; Faleck HJ; Macdonald RL;
Stroke; 2017 Jan; 48(1):145-151. PubMed ID: 27932607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
